Tracon and Case Western University Enter Cancer Agreement
Posted on: Friday, 13 October 2006, 12:01 CDT
Case Western Reserve University has entered a worldwide licensing agreement with Tracon Pharmaceuticals to develop Methoxyamine, a new cancer therapeutic that reverses cancer cell resistance to chemotherapy.
Under the licensing agreement, Tracon will develop and manage clinical trials of Methoxyamine. Methoxyamine was developed by University Hospitals Case Medical Center researchers.
Research for this new therapeutic came from the National Institutes of Health rapid access to interventional development program, that provides researchers resources and support needed for the development of new therapeutics. The NIH program focuses on a subset of small molecules, including new agents that improve the activity of established chemotherapeutics.
The patented therapy, which has been licensed to Tracon, has been studied in combination with the approved chemotherapeutic Temozolomide. Methoxyamine prevents cancer cells from repairing DNA damage caused by chemotherapy.
"The promise of overcoming a major mechanism of drug resistance in cancer is terrific news for many patients. We see potential applications in patients with brain cancers, melanoma, lung cancer and leukemia's and perhaps other cancers," said Stanton Gerson, director of the National Cancer Institute-designated Case Comprehensive Cancer Center.
Source: Datamonitor
Related Articles
- Ireland Cancer Center and Tracon Treat First Patient With Anticancer Drug
- Pharmacia and Upjohn Will Appeal Verdict in Simon Case, 'Ruling is Not Supported By the Evidence'
- FDA approves Erbitux for head, neck cancer
- STEADY PROGRESS IN CARE FOR CANCER: Two Cases, 25 Years Apart, Reveal What Has Changed in Medical Treatments and Public Perceptions
- Arms Plant Cleared in Cancer Case
- Iran TV Blames Uranium From UK Bombs of for Increase in Iraq Cancer Cases
- Wood smoke may raise lung cancer risk
- Comparison of Prostate and Breast Cancers
- CANCER CASES SET TO SOAR BY 28% ; Killer Illness on the Rise As We Live Longer
- Case Western Reserve University Scientists Test Protein As Early Cancer Detection Agent
 |
 |
User Comments (0)
RSS Feeds